溫帝國際有限公司

主成分
Orlistat contains NLT 98.0% and NMT101.5% of C29H53NO5, calculated on the anhydrous, solvent free basis. 
適應症
抗肥胖劑
主成分
 
適應症
限醫療器材管理辦法「一般醫療器械用消毒劑(J.6890)」第一等級鑑別範圍。
主成分
Hyoscine butylbromide content not less than 98.0% and not more than 101.0% of C21H30BrNO4, calculated on the dried basis. 
適應症
副交感神經抑制劑
主成分
Etofenamate content not less than 98.5% and not more than 101.5% of C18H18F3NO4, calculated on the dried basis. 
適應症
抗炎劑
主成分
Tadalafil contains NLT 97.5% and NMT 102.5% of tadalafil (C22H19O4), calculated on the dried basis.  
適應症
治療勃起功能障礙。
主成分
Lysozyme Hydrochloride Activity (on dried basis) ≧ 36.000 Units FIP/mg 
適應症
消炎酵素劑。
主成分
銀杏抽出物/Ginkgo Dry Extract, Refined and Quantified flavonoids, expressed as flavone glycosides (Mr 756.7):22.0% to 27.0% (dried extract) bilobalide:2.6% to 3.2% (dried extract) ginkgolides A, B and C:2.8% to 3.4% (dried extract) ginkgolic acids:maximum 5 ppm (dried extract) 
適應症
末梢血管循環障礙。
主成分
Levocetirizine Dihydrochloride contains NLT 98.0% and NMT 102.0% of Levocetirizine Dihydrochloride (C21H25ClN2O3‧2HCl), calculated on the dried basis.  
適應症
抗過敏製劑
主成分
Carbimazole C7H10N2O2S 186.2 Ethyl 3-methyl-2-thioxo-2, 3-dihydro-1H-imidazole-1-carboxylate. Content:98.0 percent to 102.0 percent (dried substance). 
適應症
抗甲狀腺劑
主成分
Betamethasone sodium Phosphate content not less than 96.0% and not more than 103.0% of C22H28FNa2O8P, calculated on the anhydrous basis. 
適應症
抗炎性皮質醇
主成分
Deoxycholic Acid contains not less than 97.0% and not more than 103.0% of C24H40O4, calculated on the anhydrous basis. 
適應症
乳化劑;頦下脂肪消除劑(注射)
主成分
Methyltestosterone contains NLT 97.0% and NMT 103.0% of methyltestosterone (C20H30O2), calculated on the dried basis. 
適應症
雄性激素。
主成分
Minocycline Hydrochloride Dihydrate contains not less than 94.5% and not more than 102.0% of C23H28CIN3O7‧2H2O, calculated on the anhydrous substance. 
適應症
抗生素
主成分
Betamethasone Dipropionate contains not less than 97.0% and not more than 103.0% of C28H37FO7, calculated on the dried basis. 
適應症
抗炎性皮質醇
主成分
Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C28H38N6O11S, calculated on the anhydrous substance. 
適應症
男性勃起障礙治療
主成分
Calcitriol contains not less than 97.0% and not more than 103.0% of C27H44O3 
適應症
維他命D3缺乏症
主成分
Tadalafil contains not less than 97.5% and not more than 102.0% of C22H19N3O4, calculated on the dried substance. 
適應症
男性勃起障礙治療
主成分
Betamethasone Valerate contains not less than 97.0 percent and not more than 103.0 percent of C27H37FO6, calculated on the dried basis. 
適應症
抗炎性皮質醇(外用)